What is AdaptX?
AdaptX provides a self-serve Adaptive Clinical Management solution designed to empower health systems. Its AI-driven Mission Control Center enables clinical leaders to effectively utilize real-world data for performance assessment, comparative analysis, and adaptive strategy implementation across various operational facets, including patients, teams, protocols, workflows, and facilities. The company's technology aims to deliver substantially improved patient care and enhanced financial outcomes for healthcare organizations.
How much funding has AdaptX raised?
AdaptX has raised a total of $13.1M across 3 funding rounds:
Other Financing Round
$10M
Private Equity
$2.7M
Debt
$450K
Other Financing Round (2023): $10M with participation from Memorial Hermann and Morningside Ventures
Private Equity (2025): $2.7M, investors not publicly disclosed
Debt (2025): $450K, investors not publicly disclosed
Key Investors in AdaptX
Memorial Hermann
Memorial Hermann Health System is a major not-for-profit healthcare organization providing comprehensive medical services across the Greater Houston area, likely investing to enhance clinical management within its extensive network.
Morningside Ventures
Morningside Ventures, operating in information and document management, likely provides strategic capital and operational insights to technology companies focused on data-driven solutions.
What's next for AdaptX?
The substantial enterprise-level funding and recent strategic investment indicate AdaptX is poised for significant scaling and market expansion. This capital infusion is expected to fuel further innovation in its AI-driven clinical management platform and broaden its reach within the healthcare sector. The company's focus on leveraging real-world data for adaptive clinical strategies positions it to address critical challenges in healthcare delivery, suggesting a future trajectory centered on enhancing operational efficiency and patient outcomes through advanced technological solutions.
See full AdaptX company page
